Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Last time we were at this level was mid August through mid Sept last year. Alot of positive things have happened since then. I really think it is trying to push through 2.50-2.53, I think it will, and then on to 2.75 fairly quickly. We need to see more volume to do that though. (A break above 2.53 will probably cause more volume) After that is it's high above 3.00.
2.48 when I posted this
Low was 2.24 and closed at 2.30 the day I posted this (14 Mar):
50 DMA is about to cross above the 200 DMA with 10 day and current PPS above the 50 DMA. 50 day above the 200 usually gets a positive move in PPS.
I'm expecting a move to 2.45 - 2.50 next week.
And posted this 28 Feb after CC:
How I feel after CC...No negatives, not a ton of info concerning current qtr earnings guidance or outlook (they never do) but there were positive comments on the future execution of there plan to continue progress that has been made. Also good information concerning how the steps of the JV will progress. Key for me is the fact that they will be moving into a temporary production facility, while construction begins on new facilty. IMO that means product delivery will happen before new facility is finished, thus satisfying the requirement in order to receive the additional funding from the JV agreement. Also mentioned that they will be beginning the hiring and logistics process required to get production underway. (I am guessing that is already underway in some form)
PPS outlook...possible early attempt tomorrow to drop us lower but I think we will grind higher 2.50-2.75, possibly higher, by mid-March.
Right or wrong, I'm on the record.
We made it to 2.53 this A.M....Let's finish this off by getting to 2.75 or higher!!!! I still think we are headed there within a week.
I am not, but I think they are getting close. I am leaning toward a beat of the estimates though. From all the good things that I have been seeing posted by panagis and rkt on ST I think they are making very good progress. I really want to hear that they have started production and how well it is going in China.
The reason I post this video is for the part where Mr. Smets mentions the studies they are performing with people using the vests. Valuable information that I am sure is being shared with EKSO and will lead to improved products, new products and new uses for any current and future products.
50 DMA is about to cross above the 200 DMA with 10 day and current PPS above the 50 DMA. 50 day above the 200 usually gets a positive move in PPS.
I'm expecting a move to 2.45 - 2.50 next week.
They just received $5 million from the JV with another $5 million as soon as they produce first batch of vests. Moving into temp. facility so production will start and ship before the new facility from the JV is finished being built. Plus they still have I believe $22 million left in the ATM. Add to that the profit from current quarter sales.
That's for sure...but unfortunately I am in RWLK as well at .80, .50 and .24...OUUUUUCH!!! Luckily it was profit money that I put in there.
The chart is showing VALUE (price at the time x # of shares) not the share price, so when the R/S occured the value stayed the same... price went up and # of shares went down. After the R/S happened the sp began to fall, that is when the value began to fall. That is the are I mentioned.
I believe the R/S appears where the green changes to red section in the middle of the chart. R/S ooccured on 4 May '16, so is accounted for
Check these out and tell me which company is executing and which isn't
https://www.stocksplithistory.com/?symbol=RWLK
https://www.stocksplithistory.com/?symbol=EKSO
I think that some of the confusion comes in because people wrongfully assume that because the ATM occured last year that it was finished. In actuality it is completed over time "as necessary". It does say that in the filing.
I agree with your statement on the reason for tapping into the ATM slowly.
Anyone concerned about the slow, steady and methodical way this company is executing should look into the way RWLK is executing.(or NOT executing). EKSO looks well thought out, planned and executed. RWLK looks like it is throwing out lifelines hoping someone will save them before they go under. RWLK may have 2 good products but the execution is poor. It seems as though they wait until the last minute to do something and one product to carry them through each phase. Alway behind the 8 ball. EKSO remains ahead things.
I have shares in both stocks. (at present I wish I didn't!) Too far down in RWLK to be worth getting out. Hoping for some kind of news that creates a spike so I can get out before 27 Mar R/S vote.
First, I don't like trying to discuss a point on ST beause the person may misinterpret what you/I am trying to say. Can't explain much in the limited space they give you. Also, there are a lot of uninformed speculators on there that don't do their DD and make stupid comments or just bash the company. Sometimes a person may (wrongfully) assume you/I are one of those people before thinking it through.
I don't think he has been involved in EKSO as long as we have so he is speaking from the time he came in.
He is open to discussion about the product and any articles released anywhere. You may not like his feelings about the company but you cannot agrue with the factual information he provides from he DD.
That's a good suggestion. Trying to get him to at least come to this board because it is much easier to discuss a topic or issue. I cannot believe some of the finds those 2 have been coming up with. (rkt is on this board, at least watching, haven't seen a post lately).
I think management is aware of security and IP concerns. They address much of that in the 10-K
More from 10-K:
Based upon our current cash resources, the recent rate of using cash for operations and investment, and assuming modest increases in current revenue offset by incremental increases in expenses related to increased sales and marketing and research and development, and a potential increase in rental activity from our medical device business, we believe we have sufficient resources to meet our financial obligations until the end of the second quarter of 2019. We will require significant additional financing. We intend to pursue opportunities to obtain additional financing in the future through public or private equity and/or debt financings, corporate collaborations, or warrant solicitations.
We anticipate for the foreseeable future that cash on hand and cash generated from operations will not be sufficient to meet our cash requirements, and that we will need to raise additional capital through investments to fund our operations and growth. We cannot assure you that we will be able to raise additional working or growth capital as needed on terms acceptable to us, if at all. If we are unable to raise capital as needed, we may be required to reduce the scope of our business development activities, which could harm our business plans, financial condition and operating results, or cease our operations entirely.
Additionally, our only loan agreement contains financial covenants, including a requirement of minimum cash on hand roughly equivalent to three months of cash burn. Breach of covenants included in our loan agreement could result in the lenders demanding payment of the unpaid principal and interest balances. If we fail to pay any principal or interest under our indebtedness when due,or are otherwise in violation of financial covenants under our loan agreement, it may result in the acceleration of our indebtedness, which would have a material adverse effect upon our business and would likely require us to seek to renegotiate the loan agreement with our lender or obtain a waiver for the lender, as we may not have sufficient funds to repay that indebtedness or to comply with our financial covenants. In the event that any such renegotiations are not successful or such waivers cannot be obtained on terms commercially acceptable to us, we may have to liquidate our assets at below-fair value prices, seek bankruptcy protection or implement other arrangements, any of which would or may be material adverse to our business, financial condition, assets and operations.
Reading through th 10-K and found this:
Christian Babini, who resigned as VP of Sales, Americas in January 2019
I was not aware of that. I remember when he came onboard.
Reading the 10-K will put you right to sleep...lol...some boring ass sh*t!!
How I feel after CC...No negatives, not a ton of info concerning current qtr earnings guidance or outlook (they never do) but there were positive comments on the future execution of there plan to continue progress that has been made. Also good information concerning how the steps of the JV will progress. Key for me is the fact that they will be moving into a temporary production facility, while construction begins on new facilty. IMO that means product delivery will happen before new facility is finished, thus satisfying the requirement in order to receive the additional funding from the JV agreement. Also mentioned that they will be beginning the hiring and logistics process required to get production underway. (I am guessing that is already underway in some form)
PPS outlook...possible early attempt tomorrow to drop us lower but I think we will grind higher 2.50-2.75, possibly higher, by mid-March.
Right or wrong, I'm on the record.
As I expected, nothing too different from prelim released in Jan..Prelim said 52 and 32 so pretty much the same thing.
That was one of the things that jumped out at me and the decrease in spending in several areas. I'd say they are on the right track.
I'm hoping the CC says the outlook for next qtr is continuing the trend
My opinion on the PPS reaction is that going into the report and CC I do not see a huge risk of a drastic drop in price (don't expect negative guidance). If not much guidance is given or it is not positive guidance I would expect a slide to lower levels that provides another good entry point and then a slow climb back up to 2.40-2.45+
Comments dislcosing the progress in the JV, Japanese JV and upbeat guidance and expectation of EKSOvest sales would move us to the 2.50 - 2.75 area, possibly higher.
Whichever way it goes, I will still be in. Wish I had more money to add if we drop a bit.
I agree, probably not much different from prelim. Guidance is the key IMO. It would be great if they commented on all of the points you mentioned. Based on past CC though, it will take someone specifically asking those questions during the call.
It amazes me that we get so much information from the digging of a few people here and ST (Panagis especially and RT) that EKSO does not release in a PR or comment on via social media.
With all the info that has been unearthed I am more optimistic than I have ever been but I would love to hear confirmation directly from someone at the top at EKSO.
It has been demonstrayed to Hollywood sound people. If you go to:
https://stocktwits.com/panagis1983
I asked him to repost the photos he had prviously posted about it.
If you are serious about learning about EKSO bionics, he provides the best DD that I have seen.
Thanks for your insight.
Remember, they gave preliminary report. I don't think numbers will change much if at all but the guidance/outlook for the current quarter and beyond should be more bullish than it has ever been. Hope they update on JV verture in China, mention the Japanese JV and mention EKSOVest sales aaround the globe. I really think they are purposely being cautious about what they release so that there are no spikes and collapses in SP. Slow and steady progress and slow and steady PPS increase. Much better than RWLK
Curious to know what new products are being developed?
I'm sure the military has not dropped the idea totally. We will never know what goes on behind the scenes. EKSO and others may still be contributing in some way but the big military contracts that were speculated on will not be happening any soon. So, it's back to the basics and fundamentals... how the company improves it's products and develops sales and production efforts. I still have confidence that EKSO is headed in the right direction and is executing a good plan.
This is why I questioned EKSO's involvement in the military uses some time ago and why I said industrial uses would make the money until medical devices were perfected and accepted and was the direction the company seemed to be headed.
https://exoskeletonreport.com/2019/02/following-the-u-s-military-exoskeleton-trends-is-it-going-anywhere/
To be honest I am just getting tired of the drama with J and this company. EKSO shows great potential, far less risk and no drama. I'll take a slow and steady reliable stock over hpoing for miracles with RWLK.
Looks like they DO NOT intent to use the additional 180 days...from Prospectus Supplement today
"Although we may be eligible for another cure period of 180 days after April 24, 2019 to cure the minimum bid price deficiency, it is likely that, assuming shareholder approval of the reverse share split at the 2019 annual meeting, our board will effect the reverse share split, if it does so at all, shortly after the 2019 annual meeting of shareholders and before April 24, 2019."
That would indicate to me that they feel the share price would not reach $1.00 even with the extra time, that would also suggest that news may not come as soon as we all think/hope it will. (soon enough to make PPS increase enough to comply)
I think I will ride this as high as it goes before the 27th then get out and wait until dust settles after the R/S. PPS usually drops after R/S. I may get back in then. (after 30 day period so I can write off the loss for the shares in my stock account)
Don't have time right now to read the prospectus and filing, have to go do snow/ice removal jobs. Be back in a few hours.
Not too bad of a hit...let's see what the market thinks. We've both been down to .16 before. Not many others can say that...lol
Sounds about right. As I said some time ago, they are reaching for lifelines trying to stay afloat until ReStore sales can start bringing in some money.
Another possibilty is that they are making the offering to comply with 5550(b) making them eligable for the additional 180 days they can get to comply with the $1.00 ...5550(a)
Pulling out all stops at the very last minute. The R/S vote may serve as a backstop in case they can't get CE mark and FDA approval/clearance in time to bring share price up.
So, in summary...CE mark and FDA approval should raise PPS. Will it happen in time for 24 April deadline (must be at 1.00 for 10 days, so 14 April??)
Will it bring it high enough?
In the mean time they vote on 27 Mar for R/S approval, in case they need it because PPS isn't high enough.
Also in the mean time they notify of FUTURE offering, in case they don't comply with 5550(b). They make the offering to be in compliance and then request the 180 extention in order to met the 1.00
From the 14-A...
Additionally, the Company may be eligible for a second 180 -day period to satisfy Rule 5550(a)’s minimum bid price requirement, if, as of April 24, 2019, the Company continues to have a market value of publicly held shares of at least $1 million and meets all other initial listing standards of the Nasdaq Capital Market (with the exception of the bid price requirement).
Thinking I may take some of the profit money from another stock and buy some in a day or so, when this settles. Since I am in at .80, .50 and .24 I may as well take a shot and avg. down.
That would really suck for those who jumped out.